Market Cap to Sales Ratio Analysis of Biofil Chemicals & Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsMarket Cap to Sales Ratio of BIOFILCHEM
Mar-252.01Indecisive Market Cap to Sale | Mar-242.44Not Good Market Cap to Sale | Growth-17.89% |
Market Cap to Sale Analysis of Biofil Chemicals & Pharmaceuticals Ltd.
| Market Cap to Sale Ratio of BIOFILCHEM has fallen by -17.89 % Compared to previous Financial Year. |
| Market Cap to Sale Ratio with value of 4.19 was highest in Year Mar-22 in last Five Years. |
| Market Cap to Sale Ratio of BIOFILCHEM trending down for at least three Years. |
| Latest Market Cap to Sale Ratio with value of 2.01 is lower than Average Market Cap to Sale of 2.86 in last five years. |
Other Market Cap to Sale Related Info of BIOFILCHEM that may interest you.
Biofil Chemicals & Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BIOFILCHEM | 39.79 | 39.74 | 0.126 % | Drugs & Pharma |
Defination of Market Cap to Sales Ratio
Market Capitalization to Sales Ratio is a valuation metric that compares the current price to its total sales. This metric is convenient to understand how the market is pricing every rupee sale of the company. more ..
Market Cap to Sale Related Ratios
| PriceToEarningRatio | EVToRevenue | PriceToBookRatio |
Tsr Value Index
| Poor Value Stock | Screener |
FY - Historical Market Cap to Sales Ratio of Biofil Chemicals & Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| Market Cap to Sale | 2.01 | 2.44 | 2.66 | 4.19 | 3.00 | 0.411 | 0.489 |
| Change | -17.89 % | -8.23 % | -36.52 % | 39.85 % | 629.18 % | -15.94 % | -73.18 % |
| Price | 41.16 | 60.60 | 41.40 | 57.65 | 65.85 | 7.50 | 6.95 |
| Price Change | -32.08 % | 46.38 % | -28.19 % | -12.45 % | 778.00 % | 7.91 % | -49.82 % |